<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">To date 10/67 iPSC-PD studies analyzed have used proteomic, transcriptomic, or epigenomic profiling to phenotype PD patient-derived neurons
 <sup>
  <xref ref-type="bibr" rid="CR41">41</xref>,
  <xref ref-type="bibr" rid="CR72">72</xref>,
  <xref ref-type="bibr" rid="CR76">76</xref>â€“
  <xref ref-type="bibr" rid="CR80">80</xref>,
  <xref ref-type="bibr" rid="CR87">87</xref>,
  <xref ref-type="bibr" rid="CR90">90</xref>
 </sup>. Omics analyses may be less biased and data-driven as opposed to purely hypothesis-driven
 <sup>
  <xref ref-type="bibr" rid="CR239">239</xref>
 </sup>. Data from omics studies can also help to describe biological relationships between complex intertwined cellular pathways and identify relevant druggable molecular pathways.
</p>
